Bruker (BRKR) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
21 May, 2026Opening remarks and agenda
CEO welcomed participants to the 2026 annual meeting, highlighting the virtual format for inclusivity and introduced key executives and directors present at the meeting.
Independent auditors from PricewaterhouseCoopers, LLP were introduced as the company's public accounting firm for fiscal year 2026.
Corporate governance
Secretary confirmed proper notice of the meeting, record date, and presence of a quorum with over 96% of shares represented.
Inspector of Elections was appointed to oversee voting.
Shareholder proposals
Election of three Class II directors to serve until the 2029 annual meeting was proposed.
Advisory vote on 2025 executive compensation and ratification of PricewaterhouseCoopers, LLP as independent auditors for 2026 were presented.
Latest events from Bruker
- Q2 2026 saw revenue and margin growth, offset by a $134.9M goodwill impairment charge.BRKR
Q2 2026 - Order momentum, global growth, and cost savings set the stage for margin expansion through 2027.BRKR
Jefferies Global Healthcare Conference 2026 - Q1 2026 revenue up 2.7%, EPS down, but FY guidance reaffirmed with strong bookings and cost savings.BRKR
Q1 2026 - Virtual annual meeting to vote on directors, executive pay, and auditor ratification.BRKR
Proxy filing - 2026 proxy covers director elections, say-on-pay, auditor ratification, and robust ESG and governance.BRKR
Proxy filing - FY25 revenue up 2.1% but margins fell; FY26 guidance targets EPS and margin expansion.BRKR
Q4 2025 - Q2 2024 revenue up 17.4% as acquisitions drive growth, but margins pressured by costs.BRKR
Q2 2024 - Innovation and acquisitions fuel growth in proteomics, diagnostics, and spatial biology.BRKR
Goldman Sachs 45th Annual Global Healthcare Conference - All proposals, including director elections and incentive plan, were approved by stockholders.BRKR
AGM 2025